These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8094216)

  • 1. Irritable bowel syndrome.
    Gorard DA; Dewsnap PA; Gomborone JE; Libby GW; Farthing MJ
    Lancet; 1993 Feb; 341(8842):444-5. PubMed ID: 8094216
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation as a cause of functional bowel disorders.
    Törnblom H; Abrahamsson H; Barbara G; Hellström PM; Lindberg G; Nyhlin H; Ohlsson B; Simrèn M; Sjölund K; Sjövall H; Schmidt PT; Ohman L;
    Scand J Gastroenterol; 2005 Oct; 40(10):1140-8. PubMed ID: 16265771
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance of increased human colonic permeability in response to corticotrophin-releasing hormone (CRH).
    Ferrier L
    Gut; 2008 Jan; 57(1):7-9. PubMed ID: 18094198
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome.
    Naliboff BD; Munakata J; Chang L; Mayer EA
    J Psychosom Res; 1998 Dec; 45(6):485-92. PubMed ID: 9859851
    [No Abstract]   [Full Text] [Related]  

  • 5. New insights into the pathophysiology of IBS: intestinal microflora, gas production and gut motility.
    Gasbarrini A; Lauritano EC; Garcovich M; Sparano L; Gasbarrini G
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():111-7. PubMed ID: 18924450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome.
    Grover M; Herfarth H; Drossman DA
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):48-53. PubMed ID: 18848909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on chemospecific duodenal visceral sensitivity in inflammatory bowel disease in remission.
    Minderhoud IM; Smout AJ; Oldenburg B; Samsom M
    Digestion; 2006; 73(2-3):151-9. PubMed ID: 16837799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets.
    Kraneveld AD; Rijnierse A; Nijkamp FP; Garssen J
    Eur J Pharmacol; 2008 May; 585(2-3):361-74. PubMed ID: 18417115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tests to detect GI motility disorders and GI sensation in irritable bowel syndrome].
    Okumura T
    Nihon Rinsho; 2006 Aug; 64(8):1457-60. PubMed ID: 16898612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'I feel as if my IBS is keeping me hostage!' Exploring the negative impact of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) upon university-aged women.
    Schneider MA; Fletcher PC
    Int J Nurs Pract; 2008 Apr; 14(2):135-48. PubMed ID: 18315827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Motility of the sigmoid in irritable bowel syndrome and colonic diverticulosis].
    Ritsema GH; Thijn CJ; Smout AJ
    Ned Tijdschr Geneeskd; 1990 Jul; 134(29):1398-401. PubMed ID: 2374631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome.
    Rijnierse A; Nijkamp FP; Kraneveld AD
    Pharmacol Ther; 2007 Nov; 116(2):207-35. PubMed ID: 17719089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.
    Blandizzi C
    Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.
    De Schepper HU; De Man JG; Moreels TG; Pelckmans PA; De Winter BY
    Aliment Pharmacol Ther; 2008 Apr; 27(8):621-37. PubMed ID: 18221407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are functional bowel disorders?
    Zighelboim J; Talley NJ
    Gastroenterology; 1993 Apr; 104(4):1196-201. PubMed ID: 8462809
    [No Abstract]   [Full Text] [Related]  

  • 16. "I know this is bad for me, but...": a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease: part II.
    Fletcher PC; Jamieson AE; Schneider MA; Harry RJ
    Clin Nurse Spec; 2008; 22(4):184-91. PubMed ID: 18596487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.
    Katzka DA; Loftus EV; Camilleri M
    Clin Pharmacol Ther; 2012 Sep; 92(3):306-20. PubMed ID: 22828717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropin-releasing hormone in serum.
    Ohlsson B; Sjöberg K; Alm R; Fredrikson GN
    Neurogastroenterol Motil; 2011 Nov; 23(11):1000-6, e459. PubMed ID: 21714833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The overlap between IBS and IBD: what is it and what does it mean?
    Stanisic V; Quigley EM
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):139-45. PubMed ID: 24417262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome.
    Camilleri M
    Clin Pharmacol Ther; 2012 Jan; 91(1):44-59. PubMed ID: 22071696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.